4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-020585
Chief Executive Officer sold 8,800 shares at an average $42.13 ($370,748)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…